MyMedR

Displaying all 2 publications

Abstract:

Sort:

Epidemiology of injuries among Malaysian adolescent karate athletes: A cross-sectional study

Azwan Aziz M, Kunabal P

Malays Fam Physician, 2024;19:60.
PMID: 39534766 DOI: 10.51866/oa.632

INTRODUCTION: Despite the wide range of injuries sustained by adolescents during karate, limited studies have investigated the type and frequency of sports injuries among adolescent karate athletes. This study would be the first to examine the epidemiology of injuries among adolescent karate athletes. Its objective was to describe the incidence of injuries throughout the 2023 season and the pattern of injuries among Malaysian adolescent karate athletes.
METHODS: From 1 January to 31 December 2023, this cross-sectional study examined 119 Malaysian adolescent karate athletes aged 13-19 years. Data on demographic characteristics and patterns of injuries were collected using a standardised form and analysed using SPSS version 26.
RESULTS: The incidence of injuries was 22.3 injuries per 1000 athlete exposures. Specifically, the incidence of injuries during training was 15.34 injuries per 1000 athlete exposures, while that during competition was 106.6 injuries per 1000 athlete exposures. The majority of the injuries were mild (n=113, 87.6%), while the minority were severe (n=6, 4.7%). The injuries most commonly occurred in the head and neck (n=31, 24%), followed by the ankle (n=13, 10.1%) and foot (n=14, 10.9%).
CONCLUSION: There is a need to explore the extrinsic and intrinsic risk factors of injuries among adolescent karate athletes in Malaysia, as the incidence of injuries is high during competition. Additionally, it is important to educate athletes and supporting sports science members about injury prevention programmes.
Fulltext Musculoskeletal Corticosteroid Injection during COVID-19 Pandemic in Sabah: Is It Safe?

Azwan Aziz M, Abu Hanifah R, Mohd Nahar AM

Adv Orthop, 2021;2021:8863210.
PMID: 33824767 DOI: 10.1155/2021/8863210

Musculoskeletal corticosteroid injection is commonly used as an adjunct to help patients in pain management. In this current COVID-19 pandemic, many clinicians would differ from this treatment as steroid is considered an immunosuppressive drug and could risk the patient of developing severe adverse effects if contracting COVID-19. This is a retrospective study based in Sabah, Malaysia, examining the prevalence of COVID-19 infection following musculoskeletal corticosteroid injection from 1 December 2019 until 30 June 2020 in the sports medicine clinic and the orthopedic clinic. Patients who received musculoskeletal corticosteroid injection were called by telephone and asked about visits to the emergency department or government health clinic for influenza-like illness symptoms or severe acute respiratory infection that would require screening of COVID-19. Thirty-five patients who responded to the call were included, with mean ages of 47.9 years ± 15.1. 52% were male respondents, while 48% were female. 25% of them were diabetics, and 2.9% of them had a history of lymphoproliferative disorders. The mean pain score before injection was 6.74 ± 1.03 and after injection pain was 2.27 ± 1.63. In this study, there were 11.4% (n = 4) with minor complications of steroid injection, that is, skin discoloration. Nonetheless, there were no severe complications due to corticosteroids reported. There were no reported cases of COVID-19 among the respondents following corticosteroid injection. Musculoskeletal pain would affect a person's well-being and activities; thus, its management requires that careful consideration with risk-benefit analysis be made before administering musculoskeletal corticosteroid injection during COVID-19 pandemic.

Filters

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links